Original product is a must-have for each consumer. Serialization is a primary part of ensuring the product authenticity. However, there are risks. Looking globally, approximately $15 billion of API (Active Pharmaceutical Ingredient) will be exported out of India alone this year. Though it may be serialized, it doesn’t mean there is not a possibility for drugs to sneak in and out of supply chain. In global pharma field there are no strict regulations. Policy does not balance manufacturing and distribution in every part of the world. Thus, manufacturers are responsible for playing by the rules in whatever geography they operate.
